AL
DXCM icon

Aspiriant LLC’s DexCom DXCM Stock Holding History

Aspiriant LLC’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7,226
Closed -$581K – 281
2022
Q3 		$581K Buy
7,226
+2
+0% +$169 0.03% 157
2022
Q2 		$539K Buy
7,224
+80
+1% +$7.3K 0.03% 161
2022
Q1 		$913K Sell
7,144
-156
-2% -$17.1K 0.05% 138
2021
Q4 		$980K Buy
+7,300
New +$1.05M 0.05% 137

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Aspiriant LLC's DXCM Position: Q4 2022 in Review

Aspiriant LLC sold out of DexCom (DXCM) in Q4 2022, closing a stake of 7,226 shares — an estimated $581K sold.

Aspiriant LLC first reported a position in DXCM in Q4 2021 and held it in 4 quarters. The position peaked at $980K in Q4 2021. 920 funds tracked by Wall St. Rank hold DXCM as of Q4 2022.

  • Aspiriant LLC reported no remaining DexCom position as of Q4 2022 after selling out during the quarter.
  • Aspiriant LLC sold 7,226 DexCom shares in Q4 2022, an estimated $581K.
  • Aspiriant LLC first reported a position in DexCom in Q4 2021 and held it in 4 quarters.
  • Aspiriant LLC's DexCom position peaked at $980K in Q4 2021.
  • 920 funds tracked by Wall St. Rank held DexCom as of Q4 2022.

Based on Aspiriant LLC's 13F filing for Q4 2022, filed 23 Jan 2023.